An increased SET expression and decreased PP2A activity in follicle theca cells of Polycystic Ovary Syndrome (PCOS) patients have been cited to explain the hyperandrogenism in this disease [9,10]. The gene discussed is PTPA; the disease is polycystic ovary syndrome.